Well this is interesting... a private research company in Rennes France, called Biotrial, was conducting a Phase 1 clinical trial on a new chronic
pain medication when it severely backfired. This is directly from Science, the world re-known academic science journal.

Meanwhile, the Portuguese pharmaceutical company that sponsored the trial, Bial, confirmed in a statement issued last night that the drug
tested in the study was an inhibitor of fatty acid amide hydrolase (FAAH), an enzyme that breaks down so-called endocannabinoids in the brain. FAAH
inhibitors have been proposed as a possible treatment against chronic pain.

According to the document, the trial enrolled nonsmoking men and women aged between 18 and 55 who had a body mass index between 19 and 30. The
plan was to give patients BIA 10-2474 every day between the third and thirteenth day of their stay at the clinic, while they underwent an extensive
battery of tests and sampling—including as many as nine blood collections on some days. On the first and last day of drug administration, patients'
heart rates were to be monitored around the clock while all of their urine was collected for analysis. (Between day 3 and 9, however, all they
apparently had to do was take BIA 10-2474 and provide a single blood sample.) They were due to be released on 18 January but had to come back for a
final check-up and more sampling on 1 February.

The effects were started to be seen after the third day, and the trial was halted after the fourth after all 6 people had to become hospitalized. The
trial was slated to last for 10 days and although the drug had been administered in the past, it was not given at this level of frequency and dosage.
It was also given to animals including chimpanzees with no drastic side effects.

The study was halted on Monday, and all six patients who had taken the drug were hospitalized; one is brain dead, four others have
neurological symptoms of varying severity, while one is under observation but without symptoms, neurologist Gilles Edan of the University of Rennes
Hospital Center said yesterday. MRI imaging has shown "deep, necrotic and hemorrhagic lesions in the brain" of the patients, Edan said.

Talk about bad luck and I can definitely feel for those involved! They took a chance in helping the medical community by participating in a phase 1
clinical trial (along with making a few bucks) and how they are being hospitalized for severe brain hemorrhaging. Yikes!

The original story can be found here:
www.sciencemag.org...
ow-so-far-about-clinical-trial-disaster-france

Touraine said that prosecutors in Rennes have opened an investigation and that ANSM will conduct an investigation as well. Meeting the victims and
their families today was "a moment of intense emotion," Touraine said. "The shock is even greater because people who participate [in phase I
trials] are healthy, not sick, and obviously they don't expect to be confronted with such accidents."

Phase I studies are designed to test safety and tolerability of a drug, as well as how, and how fast, the chemical is processed by the human body.
Most of these studies are carried out by specialized research contract companies; the subjects are usually healthy volunteers who receive modest
financial compensation.

I think that playing with the endocannabinoid system using synthetic drugs instead of what nature provided and making various extracts from that, if
necessary is doomed to stupid failure.

I found it interesting they were studying the endocannabinoid system. Goes to show the medical industry might know more than they want to admit about
cannabinoids (although most on ATS probably already assume that...)

That "synthetic" weed has been shown to cause deadly side effects in people. Natural cannabis, never once. And now they want to introduce
genetically modified (GMO) cannabis. ugh, so sad. stick to organics and you won't have any issues

I found it interesting they were studying the endocannabinoid system. Goes to show the medical industry might know more than they want to admit
about cannabinoids (although most on ATS probably already assume that...)

I found that interesting too. It seems the more they learn, the more they realize that cannabis and its cannabinoids are absolutely vital to our
immune systems. I'm as sure as I can be that Big Pharma, the FDA, etc., all know that cannabis works best when used whole and its various
cannabinoids and terpenes can work together to do their stuff.

But that's not patentable and controllable and -- most of all -- profitable. And, unfortunately, the laws not only allow but encourage and empower
Big Pharma to do what is in THEIR best interests. Not OURS.

Any type of "hydro" IS a GMO, cross pollinated strains ARE a GMO, cheap mexican ditch weed is the natural variety. Ya know the seedy stuff??? Those
pretty nugs with the hairs, those are man made strains.

Any type of "hydro" IS a GMO, cross pollinated strains ARE a GMO, cheap mexican ditch weed is the natural variety. Ya know the seedy stuff??? Those
pretty nugs with the hairs, those are man made strains.

Incorrect. Hydro, at least here in Holland, refers to a system of growing based on water and not soil. I will admit to ignorance what that term means
in other countries.

"Crossing" does indeed yield hybrids, sometimes. Sometimes the plant is a "hybrid" itself, however it is not and never is "GMO" as you put it. It is
natural selection. You want some Blueberry Haze? You cross the Haze with the Blueberry, two distinct strains, and sexes. Knock yourself out, it takes
knowledge, space, time and illegal growing rooms. It does not contain tomato, fish and poison based gene splices.

If you want "pure", geographically isolated strains, google "land race cannabis seeds" but these rarely grow well outside of their normal environment
without several years of expert conditioning by horticulturalists. A 12 week sativa in Holland will be a disappointment outside. Summer here is often
not much, rarely more that 8 or 9 weeks if that. Good luck!

Just wanted to add, scientists have studied cannabinoid receptors for years and years and they aren't called cannabinoid receptors because cannibis
and its constituents are the only things that target them. They have important, endogenous roles within the human body.

This content community relies on user-generated content from our member contributors. The opinions of our members are not those of site ownership who maintains strict editorial agnosticism and simply provides a collaborative venue for free expression.